Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 12, 2014TransplantationOpen Access

Acute Rejection, T-Cell–Depleting Antibodies, and Cancer After Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

WLWai H. LimThe University of SydneyRTRobin TurnerUniversity of OtagoJCJeremy R. ChapmanUniversity of Miami

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lim et al. (2014) studied this question.

synapsesocial.com/papers/6a17ad66aeefdf6d9c12d76ehttps://doi.org/10.1097/01.tp.0000442773.38510.32
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of micropapillary urothelial carcinoma of the bladder and BK viruria in kidney transplant recipients2013 · 42 citations
  2. 2Inflammation and cancer2012 · 173 citations
  3. 3Markers of systemic inflammation predict survival in patients with advanced renal cell cancer2013 · 162 citations
  4. 4Role of viruses in renal cell carcinoma.2012 · 27 citations
  5. 5Individualized T cell monitored administration of ATG versus OKT3 in steroid‐resistant kidney graft rejection2003 · 59 citations